Osteoporosis is a serious implication of Turner syndrome (TS). Common methods for the
treatment of TS are growth hormone (GHT) and estrogen replacement therapy (ERT). We …

Objective Reduced bone mineral density (BMD) is seen in Turner syndrome (TS) with an
increased risk of fractures, and body composition is characterized by increased body fat and …

Context Reduced bone mineral density (BMD) and increased risk of fractures are present in
many women with Turner syndrome (TS). Objective Examine longitudinal changes in BMD …

Patients with Turner syndrome have adverse bone and cardiovascular outcomes from
chronic estrogen deficiency. Hence, long-term estrogen replacement therapy is the …

ABSTRACT Introduction Subjects affected with Turner Syndrome (TS) suffer low bone
mineral density and high risk of fracture from a young age. Estrogen deficiency is considered …

Objective Osteoporosis is an important health issue in patients with Turner syndrome (TS),
and oestrogen sufficiency has been implicated in increased bone mineral density (BMD); …

Patients with Turner syndrome (TS) almost develop osteoporosis, resulting from
chromosomal deficiency and estrogen deficiency by gonadal dysgenesis. The aim of this …

Estrogen replacement therapy (ERT) is necessary for uterine development and bone mass
acquisition in women with Turner syndrome (TS) suffering from ovarian insufficiency …

To explore the effects of estrogen replacement therapy (ERT) and recombinant growth
hormone (GH) treatment on bone mineral density (BMD) in Turner's syndrome, we assessed …

Background: Most girls with Turner syndrome (TS) need estrogen replacement treatment
(ERT) to induce and maintain feminization and prevent osteoporosis. There is abundant …